BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1554374)

  • 1. Proteinase treatment of intact hepatic mitochondria has differential effects on inhibition of carnitine palmitoyltransferase by different inhibitors.
    Kashfi K; Cook GA
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):909-14. PubMed ID: 1554374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malonyl-CoA inhibits proteolysis of carnitine palmitoyltransferase.
    Kashfi K; Cook GA
    Biochem Biophys Res Commun; 1991 Jul; 178(2):600-5. PubMed ID: 1859420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation.
    Kashfi K; Mynatt RL; Cook GA
    Biochim Biophys Acta; 1994 May; 1212(2):245-52. PubMed ID: 8180250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane.
    Murthy MS; Pande SV
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):378-82. PubMed ID: 3540964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of the interaction of malonyl-CoA with the rat liver mitochondrial carnitine palmitoyltransferase system by using purified outer membranes.
    Kolodziej MP; Zammit VA
    Biochem J; 1990 Apr; 267(1):85-90. PubMed ID: 2327991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes.
    Murthy MS; Pande SV
    Biochem J; 1987 Dec; 248(3):727-33. PubMed ID: 3435481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topology of hepatic mitochondrial carnitine palmitoyltransferase I.
    Kashfi K; Cook GA
    Adv Exp Med Biol; 1999; 466():27-42. PubMed ID: 10709625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial carnitine palmitoyltransferase of the mitochondrial outer membrane is not altered by fasting.
    Mynatt RL; Lappi MD; Cook GA
    Biochim Biophys Acta; 1992 Sep; 1128(1):105-11. PubMed ID: 1390873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of DL-2-bromopalmitoyl-CoA and bromoacetyl-CoA in rat liver and heart mitochondria. Inhibition of carnitine palmitoyltransferase and displacement of [14C]malonyl-CoA from mitochondrial binding sites.
    Edwards MR; Bird MI; Saggerson ED
    Biochem J; 1985 Aug; 230(1):169-79. PubMed ID: 4052034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of malonyl-CoA and 2-tetradecylglycidyl-CoA with mitochondrial carnitine palmitoyltransferase I.
    Declercq PE; Venincasa MD; Mills SE; Foster DW; McGarry JD
    J Biol Chem; 1985 Oct; 260(23):12516-22. PubMed ID: 3840167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine palmitoyltransferase in the heart is controlled by a different mechanism than the hepatic enzyme.
    Cook GA; Lappi MD
    Mol Cell Biochem; 1992 Oct; 116(1-2):39-45. PubMed ID: 1480153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic mitochondrial inner membrane properties and carnitine palmitoyltransferase A and B. Effect of diabetes and starvation.
    Brady LJ; Silverstein LJ; Hoppel CL; Brady PS
    Biochem J; 1985 Dec; 232(2):445-50. PubMed ID: 4091801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a solubilized malonyl-CoA-sensitive carnitine palmitoyltransferase from the mitochondrial outer membrane as a protein distinct from the malonyl-CoA-insensitive carnitine palmitoyltransferase of the inner membrane.
    Murthy MS; Pande SV
    Biochem J; 1990 Jun; 268(3):599-604. PubMed ID: 2363698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and proteolysis: effects on carnitine palmitoyltransferase-I and malonyl-CoA binding.
    Kashfi K; Cagen L; Cook GA
    Lipids; 1995 May; 30(5):383-8. PubMed ID: 7637557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
    Brady PS; Brady LJ
    Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane.
    Fraser F; Corstorphine CG; Zammit VA
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):711-8. PubMed ID: 9169604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interacting effects of L-carnitine and malonyl-CoA on rat liver carnitine palmitoyltransferase.
    Bird MI; Saggerson ED
    Biochem J; 1985 Aug; 230(1):161-7. PubMed ID: 4052033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine acyltransferase activities in rat liver and heart measured with palmitoyl-CoA and octanoyl-CoA. Latency, effects of K+, bivalent metal ions and malonyl-CoA.
    Saggerson ED
    Biochem J; 1982 Feb; 202(2):397-405. PubMed ID: 7092822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of hepatic carnitine palmitoyltransferase. Use of bromoacyl derivatives and antibodies.
    Brady PS; Dunker AK; Brady LJ
    Biochem J; 1987 Feb; 241(3):751-7. PubMed ID: 3593221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA are due to differences in Ki values.
    Cook GA
    J Biol Chem; 1984 Oct; 259(19):12030-3. PubMed ID: 6480597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.